screen_shot_2013-11-19_at_08

Immunocore promotes non-executive to chairman

November 19, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing immunocore, knowles

Oxford-based biotech firm Immunocore has appointed Dr Jonathan Knowles as the new executive chairman of its Board of directors. Knowles …

Sanofi image

Sanofi discards blood cancer drug in late-stage

November 19, 2013
Research and Development, Sales and Marketing Sanofi, Wernicke's encephalopathy, fedratinib

Sanofi has scrapped its regulatory filing plans and late-stage trials for rare bone marrow cancer treatment fedratinib. The reason given …

cancer image

Scientists map cancer ‘family tree’

November 18, 2013
Research and Development, Sales and Marketing Cancer, DNA, ICR, family tree

A method to take the DNA fingerprint of individual cancer cells is uncovering the true extent of cancer’s genetic diversity …

Xofigo

Bayer cancer drug gets EU approval

November 18, 2013
Sales and Marketing Bayer, CHMP, EU, Xtandi, Zytiga, xofigo

Bayer’s prostate cancer treatment Xofigo has been shown the green light by the European Commission.  Xofigo (radium Ra 223 dichloride) …

China image

Merck and J&J invest in Chinese manufacturing

November 18, 2013
Manufacturing and Production J&J, JJ, Merck, manufacturing

Merck KGaA and Johnson & Johnson have both announced new manufacturing projects in China, suggesting investigations into corruption by the …

Lilly image

Lilly plans $700m insulin plant expansion programme

November 18, 2013
Manufacturing and Production Taylor, lilly, manufacturing

Eli Lilly has said it will invest more than $700 million to expand its production capacity for insulin products in …

EMA image

UK agency urged to ‘press’ EMA on speed reviews

November 18, 2013
Research and Development, Sales and Marketing BIA, EMA, EU, MHRA

A new advisory group for the UK drugs regulator wants Europe to follow the lead of the US by introducing …

NICE image

NICE tells pharma: don’t blame us for rejections

November 18, 2013
Sales and Marketing Dillon, NHS, NICE, VBP

The head of NICE has publicly defended his agency against more pharma criticism but admits that it can make changes …

Pharma facility news in brief

November 18, 2013
Manufacturing and Production Actavis, Bend Research and WuXi PharmaTech, China Pharma, GlaxoSmithKline, manufacturing, nibs

GlaxoSmithKline is planning to boost in-house production of pharmaceuticals in India by building a brand new facility with an investment …

giovanni-caforio-2011-2

Several leadership changes at Bristol-Myers Squibb

November 18, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS

BMS has made several modifications to its senior management team with appointments and role shuffles being the order of the …

Hunt image

Is the NHS in safe hands?

November 18, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hunt, Lansley, McConaghie, NHS

A total of 16 months have passed since Jeremy Hunt took over as health secretary from Andrew Lansley, and in …

Most health apps have ‘limited value’

November 15, 2013
Medical Communications, Sales and Marketing Android, digital, healthcare apps, smartphone apple

In a challenge to pharma marketers everywhere, a new report has declared that the ‘vast majority’ of health-related apps aimed …

‘Old fashioned’ doctors in new GP contract

November 15, 2013
Sales and Marketing BMA, GP, Hunt, Labour, NHS, UK, doctors

The government is changing GPs’ contract with the NHS in a bid to “bring back old-fashioned family doctors” who will …

Pharma slams PPRS deal

November 15, 2013
Medical Communications, Sales and Marketing ABPI, PPRS, VBP, telegraph

The fallout from last week’s new drug pricing plan in the UK is continuing as nine pharma firms write an …

g_kelly_martin_questcor

Questcor adds Elan president to its Board

November 15, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Elan, Questcor, martin

Biopharma firm Questcor Pharmaceuticals has appointed Elan’s president and chief executive G. Kelly Martin to its Board of directors. Martin has …

Roche image

Roche signs $17 million immatics deal

November 15, 2013
Research and Development, Sales and Marketing Cancer, Roche, immatics, lung, prostate

Roche is to pay German biotech company immatics $17 million to collaborate on the search for vaccines in various cancers, …

Johnson and Johnson image

J&J ‘to pay out $4 billion’ in fresh legal case

November 14, 2013
Sales and Marketing J&J, JJ, Risperdal, fines, hip replacement

Johnson & Johnson is set to pay up to $4 billion to settle thousands of legal cases related to patients …

Typhoon image

Philippines typhoon: pharma response

November 14, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Philippines typhoon, pharma

Staff from pharma companies on the ground in the Philippines appear to have escaped the worst following the typhoon which …

janssen image

Janssen/Pharmacyclics gain FDA nod for Imbruvica

November 14, 2013
Sales and Marketing FDA, Janssen, Pharmacyclics, Revlimid, Velcade

The FDA has approved Janssen and Pharmacyclics’ Imbruvica to treat patients with mantle cell lymphoma (MCL), a rare and aggressive …

EMA image

EMA delays data transparency

November 14, 2013
Medical Communications, Research and Development, Sales and Marketing EMA, FDA, all trials, transparency

The European Medicines Agency has delayed its much-trailed plan to launch a clear policy on making clinical trial data publically …

The Gateway to Local Adoption Series

Latest content